Trialect

+ More Filters

Reset Filters

Specialty

Funding Organization

Funding Type

Eligible Country

Deadline

From

Other (Select all that apply)

Show Expired Programs

Show Verified Programs

Verified

Award for Distinguished Research in the Biomedical Sciences in AAMC

Association of American Medical Colleges(AAMC)

The Award for Distinguished Research in the Biomedical Sciences honors an individual or a team of two individuals for outstanding research in the basic or translational sciences. The AAMC has awarded this prize since 1947.

The awardee receives the Research Award and a prize of $10,000. Nominations are due Jan. 24, 2025.

Guidelines for Entry

Individuals or teams of two individuals may be nominated. All nominees must have a faculty appointment at AAMC-member medical schools or teaching hospitals, but rank is not a criterion for this award.

Anyone may submit a nomination. Nominations must be received by Jan. 24, 2025, via the electronic entry form. The fields required for nomination can be previewed here.

The review committee will select up to three finalists. Nominators of finalists will be notified by March 7, 2025, that they are invited to submit additional materials. Final-round additional materials must include:

One two-page letter of support of the finalist authored by an AAMC-member institution’s dean, chief executive officer, or president on institutional letterhead.
Two additional two-page letters of support attesting to how the finalist demonstrates the criteria of the Research Award.
Copies of up to five key publications by the nominee.

Additional support materials must be submitted by April 4, 2025. There is no need to compile these resources before notification on March 7.

The winner of the award will be notified by July 11, 2025, and honored during the AAMC Virtual Awards Recognition event.

Please address all questions to:
Sandra Gordon
202-828-0472
sgordon@aamc.org

Recipients of the Award for Distinguished Research in the Biomedical Sciences

The Award for Distinguished Research in Biomedical Sciences honors an individual or a team of two individuals for outstanding research in the basic or translational sciences.

Garret A. FitzGerald, MD, FRS, is the 2024 recipient of the Award for Distinguished Research in the Biomedical Sciences. Dr. FitzGerald is Director, Institute for Translational Medicine and Therapeutics at the University of Pennsylvania.

Specialties

Biochemistry

Healthcare Delivery

Molecular Biology

Cardiovascular Diseases

Microbiology

Eligibility Requirements

Nominees will be evaluated by the review committee on the following precise criteria:

The nominee’s research contributions have resulted in significant or novel discoveries.
The nominee’s research discoveries have advanced a scientific paradigm.
The nominee’s research discoveries have the potential to lead to, or have already led to, significant benefits to human health and well-being (either by the nominee directly or by others who may be or have been enabled by the nominee’s foundational discoveries).
The nominee demonstrates contributions to biomedical research beyond their own work (e.g., mentoring, review panels, task forces, editorial boards).
The nominee demonstrates standards of professional ethics and scientific integrity.

Nominees should demonstrate excellence in all criteria listed above.

Sponsor Details

Sponsor Institute/Organizations: Association of American Medical Colleges(AAMC)

Address: 655 K Street, NW, Suite 100 Washington, DC 20001-2399 202-828-0400

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity